Advisors Preferred »

Neurocrine Biosciences shares owned by Advisors Preferred

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Advisors Preferred from 13F filings

Historical chart of Advisors Preferred investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Advisors Preferred consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Advisors Preferred

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.2M 30k 140.60

More positions owned by Advisors Preferred

iShares Russell 2000 Value ETF USD Class Etf (IWN)
State Street Financial Select Sector SPDR ETF USD Class Etf (XLF)
Invesco Nasdaq 100 ETF USD Class Etf (QQQM)
Schwab US Dividend Equity ETF USD Class Etf (SCHD)
iShares 0 to 3 Month Treasury Bond ETF USD Class Etf (SGOV)
State Street SPDR S&P 500 ETF Trust USD Class Etf (SPY)
iShares Russell 1000 Value ETF USD Class Etf (IWD)
Vanguard Russell 1000 Growth ETF Etf (VONG)
NVIDIA Corporation (NVDA)
Vanguard Dividend Appreciation ETF USD Class Etf (VIG)
BondBloxx Bloomberg Six Month Target Duration US Treasury ETF Etf (XHLF)
BNY Mellon US Large Cap Core Equity ETF USD Class Etf (BKLC)
SPDR Bloomberg 1to 3 Month T-Bill ETF USD Class Etf (BIL)
Apple (AAPL)
iShares 7 to 10 Year Treasury Bond ETF USD Class Etf (IEF)

View all positions for Advisors Preferred

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Thomas Stevens, CFA"
Deerfield Management Company
Rtw Investments
Millennium Management
UBS Group

View all funds holding Neurocrine Biosciences